Image of cancer cells

Radiopharm approved to start Lu-RAD202 safety trials, door open for in-human studies

Radiopharm Theranostics has received ethics approval for its trial into Lu-RAD202, a novel treatment for these…
Myelofibrosis cells in blood flow

Clinical trial data for MF candidate proves promising for Syntara

Syntara Ltd has reported positive interim results from its Phase 2 trial to test the efficacy…
The Market Online Video

Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial

Recce Pharmaceuticals Ltd has secured approval for a Phase 3 trial on its treatment candidate to…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…
AI image of a medical researcher

Radiopharm extends radioimmunotherapy trial to 5 more cancer types

Radiopharm Theranostics Ltd has received approval to extend its Phase 1 trial of Lu-RAD204 to five…
Medical professional holding a tablet

InhaleRX gains approval for clinical trial to test non-opioid therapy for cancer pain

InhaleRX Ltd has received approval for a Phase 2 clinical trial to test its novel therapy…
Image representing bacterial infections in the immune system

Recce reaches key dosing milestone in testing of skin infection gel

Recce Pharmaceuticals Ltd has successfully dosed 20 out of 30 participants in its Phase II trial…
Image of the human circulatory system

4DMedical secures $1.9M grant to ramp-up trials for ‘safer, cheaper’ lung imaging

The Federal government has awarded 4DMedical Ltd a grant worth $1.9M to fund its clinical trials…
AI image of a microscope.

Amplia moves to next stage of cancer drug trial for narmafotinib

Amplia Therapeutics Ltd is set to move further through its Phase 2a trial for cancer drug…
The Market Online Video

Recce reaches testing milestone for UTI, Uroseptis antibiotic

Recce Pharmaceuticals Limited (ASX: RCE) has completed tests involving a four-person cohort for its RECCE 327…